Callio leaders delivered three presentations and two panel discussions on dual-payload ADC resistance, manufacturability, linker design, and the path to next-generation ADCs October 15, 2026 08:00 ET  | Source: Callio Therapeutics SAN DIEGO, SEATTLE and SINGAPORE, Oct. 15, 2026 (GLOBE NEWSWIRE) — Callio Therapeutics (“Callio” or “the Company”), a global, clinical-stage biotechnology company advancing dual-payload

Zymeworks to Report Third Quarter 2026 Financial Results on November 9, 2026 October 15, 2026 06:00 ET  | Source: Zymeworks Inc. VANCOUVER, British Columbia, Oct. 15, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced

October 15, 2026 04:00 ET  | Source: Royal Philips October 15, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the five-year EXIT-CVD research project, co-funded by the European Union Innovative Health Initiative (IHI) and the industry partners. The research consortium is

October 14, 2026 09:05 ET  | Source: Kyowa Kirin, Inc. PRINCETON, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced the publication of three-year real-world findings from an interim analysis of the XLH Disease Monitoring Program (DMP) in the Journal of

Based on verified customer reviews, the recognition spans Cority’s environmental health and safety and occupational health and safety solutions October 14, 2026 08:00 ET  | Source: Cority Software Inc. TORONTO, Oct. 14, 2026 (GLOBE NEWSWIRE) — Cority, the intelligent EHS+ platform that helps customers see and prevent risks across their operations, announced today that it

October 14, 2026 08:00 ET  | Source: Adagene Inc. SAN DIEGO and SUZHOU, China, Oct. 14, 2026 (GLOBE NEWSWIRE) — Adagene Inc. (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will participate in

Company to highlight integrated capabilities spanning custom material formulations, precision extrusion, catheter construction and finished-device assembly. October 13, 2026 12:57 ET  | Source: TekniPlex Wayne, PA, Oct. 13, 2026 (GLOBE NEWSWIRE) — TekniPlex Healthcare will showcase its comprehensive materials science, precision extrusion and interventional-device manufacturing capabilities at MD&M Midwest 2026, taking place October 28–29 at

October 13, 2026 08:00 ET  | Source: Acadian Seaplants Ltd. Dartmouth, Nova Scotia, Oct. 13, 2026 (GLOBE NEWSWIRE) — Acadian Animal Wellness today announced the global launch of Tasco®, an optimized feed technology for animal feed products. Based on the seaweed Ascophyllum nodosum, Tasco is a premium marine bioactive technology with prebiotic, stress-relieving, and immune-supporting

October 12, 2026 17:45 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026. At the R&D Day, Teva’s leadership will discuss its R&D pipeline, its near-term

October 12, 2026 06:00 ET  | Source: Wellcome Leap Inc. BERLIN, Oct. 12, 2026 (GLOBE NEWSWIRE) — The Gates Foundation and Wellcome Leap today announced a new initiative called Uzima: A Stillbirth Prevention Program, which aims to demonstrate that stillbirth rates can be reduced by half over the next decade across select countries. Uzima will

October 09, 2026 07:00 ET  | Source: Teva Pharmaceutical Industries Ltd Teva will hold an investor call and live webcast on Friday, October 9, 2026, 8:00 a.m. ET PARSIPPANY, N.J. and TEL AVIV, Israel, Oct. 09, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today

October 09, 2026 00:26 ET  | Source: TherapiAI YOKOHAMA, Japan, Oct. 09, 2026 (GLOBE NEWSWIRE) — TherapiAI, a Taipei-based developer of AI agents for drug development and manufacturing, showcased its Biopharma AI Operating Layer at BioJapan 2026 this week as it works to expand its presence in Japan. Designed for biopharmaceutical companies and contract development

October 07, 2026 09:56 ET  | Source: Medela Baar, Switzerland, Oct. 07, 2026 (GLOBE NEWSWIRE) — Medela, a global leader in healthcare technology, today announced the expansion of Drainology™, a scientific initiative dedicated to advancing evidence-based chest drain management through research, education and clinical collaboration. With new digital channels, expert-led educational resources and scientific events,

October 06, 2026 04:00 ET  | Source: Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will take center stage at this week’s International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit

October 05, 2026 09:00 ET  | Source: Curia Global, Inc. ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API manufacturing capabilities for both steroid and non-steroid products in Valladolid, Spain. This expansion is